Literature DB >> 15240592

GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone.

Astrid U Meysing1, Haruhiko Kanasaki, Gregoy Y Bedecarrats, James S Acierno, P Michael Conn, Kathryn A Martin, Stephanie B Seminara, Janet E Hall, William F Crowley, Ursula B Kaiser.   

Abstract

Mutations in the GnRH receptor gene (GNRHR) are a cause of idiopathic hypogonadotropic hypogonadism. We describe a normosmic female subject with congenital idiopathic hypogonadotropic hypogonadism in whom treatment with pulsatile GnRH resulted in an unusual response. The subject not only required an increased dose of pulsatile GnRH for ovarian follicular development, but LH secretion did not increase appropriately, estradiol levels remained low, and she did not ovulate spontaneously. Sequencing of the GNRHR coding sequence revealed compound heterozygous mutations leading to amino acid substitutions [N10K+Q11K] and P320L. The introduction of the P320L mutation into the GnRH receptor led to failure of detectable ligand binding and failure of stimulation of inositol phosphate production and gonadotropin subunit gene promoter activity in response to GnRH in transiently transfected cells. The [N10K+Q11K] mutation resulted in reduced binding of a GnRH agonist to 25% of the wild-type receptor. In addition, the EC(50) value for GnRH stimulation of inositol phosphate production was significantly increased, and the dose-response curves for stimulation of alpha gonadotropin subunit, LHbeta, and FSHbeta gene transcription by GnRH were similarly shifted to the right. Stimulation of FSHbeta gene transcription was more sensitive to GnRH than LHbeta for both wild-type and [N10K+Q11K] GnRH receptors, resulting in a greater loss of LHbeta stimulation than FSHbeta by the [N10K+Q11K] mutant at any given submaximal GnRH concentration. We propose that the mutations in the GnRH receptor result in a rightward shift of the dose-response curves of gonadotropin responses to pulsatile GnRH in the subject and unmask the differential sensitivities of LH and FSH to GnRH, resulting in low LH and estradiol levels despite appropriate FSH secretion and follicular growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240592     DOI: 10.1210/jc.2003-031808

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  G protein-coupled receptors involved in GnRH regulation: molecular insights from human disease.

Authors:  Sekoni D Noel; Ursula B Kaiser
Journal:  Mol Cell Endocrinol       Date:  2011-06-29       Impact factor: 4.102

Review 2.  Genotype and phenotype of patients with gonadotropin-releasing hormone receptor mutations.

Authors:  Hyung-Goo Kim; Jennifer Pedersen-White; Balasubramanian Bhagavath; Lawrence C Layman
Journal:  Front Horm Res       Date:  2010-04-08       Impact factor: 2.606

3.  When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR).

Authors:  Elena Gianetti; Janet E Hall; Margaret G Au; Ursula B Kaiser; Richard Quinton; Jane A Stewart; Daniel L Metzger; Nelly Pitteloud; Veronica Mericq; Paulina M Merino; Lynne L Levitsky; Louise Izatt; Mariarosaria Lang-Muritano; Victor Y Fujimoto; Robert G Dluhy; Matthew L Chase; William F Crowley; Lacey Plummer; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

4.  Expanding the phenotype and genotype of female GnRH deficiency.

Authors:  Natalie D Shaw; Stephanie B Seminara; Corrine K Welt; Margaret G Au; Lacey Plummer; Virginia A Hughes; Andrew A Dwyer; Kathryn A Martin; Richard Quinton; Veronica Mericq; Paulina M Merino; James F Gusella; William F Crowley; Nelly Pitteloud; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-01-05       Impact factor: 5.958

Review 5.  Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Adv Pharmacol       Date:  2011

6.  Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism.

Authors:  Brent S Abel; Natalie D Shaw; Jenifer M Brown; Judith M Adams; Teresa Alati; Kathryn A Martin; Nelly Pitteloud; Stephanie B Seminara; Lacey Plummer; Duarte Pignatelli; William F Crowley; Corrine K Welt; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-01-22       Impact factor: 5.958

7.  Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism.

Authors:  Taneli Raivio; Yisrael Sidis; Lacey Plummer; Huaibin Chen; Jinghong Ma; Abir Mukherjee; Elka Jacobson-Dickman; Richard Quinton; Guy Van Vliet; Helene Lavoie; Virginia A Hughes; Andrew Dwyer; Frances J Hayes; Shuyun Xu; Susan Sparks; Ursula B Kaiser; Moosa Mohammadi; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

8.  Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay.

Authors:  Daiane Beneduzzi; Ericka B Trarbach; Le Min; Alexander A L Jorge; Heraldo M Garmes; Alessandra Covallero Renk; Marta Fichna; Piotr Fichna; Karina A Arantes; Elaine M F Costa; Anna Zhang; Oluwaseun Adeola; Junping Wen; Rona S Carroll; Berenice B Mendonça; Ursula B Kaiser; Ana Claudia Latronico; Letícia F G Silveira
Journal:  Fertil Steril       Date:  2014-07-10       Impact factor: 7.329

Review 9.  Genetic insights into human isolated gonadotropin deficiency.

Authors:  Ericka Barbosa Trarbach; Leticia Gontijo Silveira; Ana Claudia Latronico
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

10.  Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review.

Authors:  Bernd Th Krause; Ralf Ohlinger; Annette Haase
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.